/NDATF

NDATF Stock - nDatalyze Corp.

Q: What is the analyst price target for NDATF?

Analyst price target information is not currently available for NDATF.

Q: What is NDATF's market cap?

Market capitalization information is not currently available for NDATF.

Healthcare|Medical - Healthcare Information Services|OTC

$0.01+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.01

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for NDATF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

FY2025

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.24

52W High$0.06

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$1,714	$96,342	$171,215	$424,928	$662,768
Gross Profit	$1,553	$67,389	$44,844	$229,977	$376,732
Gross Margin	90.6%	69.9%	26.2%	54.1%	56.8%
Operating Income	$-637,959	$-455,381	$-941,520	$-903,342	$-586,773
Net Income	$-554,476	$-155,601	$-1,232,103	$-1,173,481	$-698,527
Net Margin	-32349.8%	-161.5%	-719.6%	-276.2%	-105.4%
EPS	$-0.01	$-0.00	$-0.03	$-0.03	$-0.03

Company Overview

nDatalyze Corp. generates technology-based health-related solutions. It is developing a machine-learning based online consumer mental health application and database licensing. The company also engages in the manufacture and sale of essential oil CO2 extraction and alcohol-based equipment. It serves medical cannabis growers. The company was formerly known as MedXtractor Corp. and changed its name to nDatalyze Corp. in October 2021. nDatalyze Corp. was incorporated in 2018 and is headquartered in Calgary, Canada.

Visit Website

Frequently Asked Questions about NDATF

What is NDATF's current stock price?

nDatalyze Corp. (NDATF) is currently trading at $0.01 per share. The stock has moved +0.00% today.

What is the analyst price target for NDATF?

No analyst price targets are currently available for this stock.

What sector is nDatalyze Corp. in?

nDatalyze Corp. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the OTC exchange.

What is NDATF's market cap?

nDatalyze Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does NDATF pay dividends?

No, nDatalyze Corp. does not currently pay a dividend to shareholders.